BRPI0714317A2 - Utilização de derivados de imidazo [ 1,2-alfa] piridina -21- carboxamidas em terapêutica. - Google Patents
Utilização de derivados de imidazo [ 1,2-alfa] piridina -21- carboxamidas em terapêutica.Info
- Publication number
- BRPI0714317A2 BRPI0714317A2 BRPI0714317-6A2A BRPI0714317A BRPI0714317A2 BR PI0714317 A2 BRPI0714317 A2 BR PI0714317A2 BR PI0714317 A BRPI0714317 A BR PI0714317A BR PI0714317 A2 BRPI0714317 A2 BR PI0714317A2
- Authority
- BR
- Brazil
- Prior art keywords
- imidazo
- therapeutics
- pyridine
- alpha
- carboxamide derivatives
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 2
- 229940053202 antiepileptics carboxamide derivative Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0606013A FR2903108B1 (fr) | 2006-07-03 | 2006-07-03 | Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique. |
PCT/FR2007/001127 WO2008003858A2 (fr) | 2006-07-03 | 2007-07-03 | Utilisation de dérivés d'imidazo[1, 2-a]pyridine-2-carboxamides en thérapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0714317A2 true BRPI0714317A2 (pt) | 2014-06-24 |
Family
ID=37846294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0714317-6A2A BRPI0714317A2 (pt) | 2006-07-03 | 2007-07-03 | Utilização de derivados de imidazo [ 1,2-alfa] piridina -21- carboxamidas em terapêutica. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20090149494A1 (pt) |
EP (1) | EP2043643A2 (pt) |
JP (1) | JP2009541473A (pt) |
KR (1) | KR20090034861A (pt) |
CN (1) | CN101484168A (pt) |
AU (1) | AU2007271010A1 (pt) |
BR (1) | BRPI0714317A2 (pt) |
CA (1) | CA2656363A1 (pt) |
FR (1) | FR2903108B1 (pt) |
IL (1) | IL195949A0 (pt) |
MX (1) | MX2008016550A (pt) |
RU (1) | RU2009103302A (pt) |
WO (1) | WO2008003858A2 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2903107B1 (fr) * | 2006-07-03 | 2008-08-22 | Sanofi Aventis Sa | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
FR2925903B1 (fr) * | 2008-01-02 | 2011-01-21 | Sanofi Aventis | DERIVES 6-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
FR2925900B1 (fr) * | 2008-01-02 | 2011-03-04 | Sanofi Aventis | DERIVES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
FR2925906B1 (fr) * | 2008-01-02 | 2010-08-20 | Sanofi Aventis | COMPOSES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
JP6284490B2 (ja) * | 2012-12-28 | 2018-02-28 | 株式会社新日本科学 | イミダゾピリジン誘導体を有効成分として含むoct3活性阻害剤又はoct3検出剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6379666B1 (en) * | 1999-02-24 | 2002-04-30 | Edward L. Tobinick | TNF inhibitors for the treatment of neurological, retinal and muscular disorders |
DE10117184A1 (de) * | 2001-04-05 | 2002-10-17 | Gruenenthal Gmbh | Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen |
GB0303503D0 (en) * | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
FR2903107B1 (fr) * | 2006-07-03 | 2008-08-22 | Sanofi Aventis Sa | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
FR2925900B1 (fr) * | 2008-01-02 | 2011-03-04 | Sanofi Aventis | DERIVES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
FR2925901B1 (fr) * | 2008-01-02 | 2011-03-04 | Sanofi Aventis | DERIVES DE N-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
-
2006
- 2006-07-03 FR FR0606013A patent/FR2903108B1/fr not_active Expired - Fee Related
-
2007
- 2007-07-03 WO PCT/FR2007/001127 patent/WO2008003858A2/fr active Application Filing
- 2007-07-03 EP EP07803835A patent/EP2043643A2/fr not_active Withdrawn
- 2007-07-03 RU RU2009103302/15A patent/RU2009103302A/ru not_active Application Discontinuation
- 2007-07-03 JP JP2009517334A patent/JP2009541473A/ja not_active Withdrawn
- 2007-07-03 CN CNA2007800252246A patent/CN101484168A/zh active Pending
- 2007-07-03 BR BRPI0714317-6A2A patent/BRPI0714317A2/pt not_active IP Right Cessation
- 2007-07-03 KR KR1020097000051A patent/KR20090034861A/ko not_active Application Discontinuation
- 2007-07-03 AU AU2007271010A patent/AU2007271010A1/en not_active Abandoned
- 2007-07-03 CA CA002656363A patent/CA2656363A1/fr not_active Abandoned
- 2007-07-03 MX MX2008016550A patent/MX2008016550A/es active IP Right Grant
-
2008
- 2008-12-15 IL IL195949A patent/IL195949A0/en unknown
- 2008-12-17 US US12/337,018 patent/US20090149494A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL195949A0 (en) | 2009-09-01 |
KR20090034861A (ko) | 2009-04-08 |
EP2043643A2 (fr) | 2009-04-08 |
CA2656363A1 (fr) | 2008-01-10 |
FR2903108B1 (fr) | 2008-08-29 |
FR2903108A1 (fr) | 2008-01-04 |
WO2008003858A3 (fr) | 2008-04-17 |
US20090149494A1 (en) | 2009-06-11 |
WO2008003858A2 (fr) | 2008-01-10 |
AU2007271010A1 (en) | 2008-01-10 |
MX2008016550A (es) | 2009-02-12 |
RU2009103302A (ru) | 2010-08-10 |
CN101484168A (zh) | 2009-07-15 |
JP2009541473A (ja) | 2009-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2007000080A (es) | Piridin [3,4-b] pirazinonas | |
BRPI0822237A2 (pt) | Compostos de imidazo [1,2-a] piridina | |
NO2014006I1 (no) | Vemurafenib. Propan-l-sulfonsyre3-[5-(4-klorfenyl)-lH-pyrrolo[2,3-b]pyridin-3-karbonyl]-2,4-difluor-fenyl-amid | |
DK2229391T3 (da) | Pyrido[2,3-B]pyrazin-8-substituerede forbindelser og deres anvendelse | |
IL193270A0 (en) | Octahydro-pyrrolo[3,4-b] pyrrole derivatives and their use as histamine-3 receptor | |
IL185484A0 (en) | Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents | |
IL200695A (en) | History of Hydro-Oxazolo [2,3-a] Pyrimidine-7-Wen and Pharmaceutical Preparations Containing Them | |
IL211890A0 (en) | Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof | |
IL196671A0 (en) | Substituted imidazolone derivatives, preparation and uses | |
HK1131747A1 (en) | Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors | |
BRPI0923099A2 (pt) | "indicação de sincronização em redes". | |
DE102008005493A8 (de) | 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate | |
BRPI0914665A2 (pt) | derivados de pirimido[2,1-a]isoquinolin-4-ona substituída | |
IL198239A0 (en) | Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a] pyrimidin -6- one and 8-piperidinyl-2- pyrimidinyl [1,2-a] pyrimidin -6- one derivatives | |
BRPI0822223A2 (pt) | Derivados de imidazo [1,2-alfa] piridina-2-carboxamidas, sua preparação e sua aplicação em terapêutica | |
BRPI0714317A2 (pt) | Utilização de derivados de imidazo [ 1,2-alfa] piridina -21- carboxamidas em terapêutica. | |
FR2873118B1 (fr) | Derives de pyrido-pyrimidine, leur application en therapeutique | |
IL193384A0 (en) | Substituted prolinamides, their preparation and their use as pharmaceuticals | |
IL198481A0 (en) | Pyrrole derivatives, preparation use of the same in therapy | |
BRPI0821992A2 (pt) | Derivados de n-heterocíclico-imidazo[1,2-a]piridina-2-carboxamida s, respectivo preparo e respectiva aplicação em terapêutica | |
ZA201008178B (en) | Imidazo [2,1-b]quinazolin-2-one derivatives and their use as platelet anti-aggregative agents | |
DK2059521T3 (da) | Pyrazolo[1,5-A]pyrimidiner, fremgangsmåder, anvendelse og sammensætninger | |
BRPI0821458A2 (pt) | Derivado 6-heterocíclico-imidazo[1,2-a]pirroína-2-carboxamida s, o respectivo preparo e a respectiva aplicação em, terapêutica | |
IL206666A0 (en) | N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2- | |
BRPI0807880A2 (pt) | Composição anestésica em spray. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 6A E 7A ANUIDADES. |
|
B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |